HSP90 inhibition drives GRP78 relocalization to potentiate CAR-based immunotherapy during tumor evolution

Published in Molecular Cancer, 2026

Recommended citation: Sabha Y, Cho JH, Zhang X, Haggerty J, Ai A, Mayorga A, Rajpoot S, Chen CH, Bulatowicz JJ, Byrne M, Cruz MA, Xynogala A, Liu C, Chen F, Gause WC, Wang X, Fu K, Fritzky L, Qin Y, Simonishvili S, Zhou Z, Liu C, Lamenze A, Wei Z, Beaulieu AM, Birge RB, Lunsford KE, Liu D. HSP90 inhibition drives GRP78 relocalization to potentiate CAR-based immunotherapy during tumor evolution. Mol Cancer. 2026. doi:10.1186/s12943-026-02807-2 https://link.springer.com/article/10.1186/s12943-026-02807-2